Trial Profile
A Phase 2 trial of MYK-461 in paediatric patients with hypertrophic cardiomyopathy (nHCM)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2017
Price :
$35
*
At a glance
- Drugs Mavacamten (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Therapeutic Use
- 27 Jun 2017 New trial record